Mitochondrial component of calcium signaling abnormality in autism

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 207-224

  Jay Gargus, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81355126551     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Abrahams, B.S. and Geschwind, D.H. (2008). Advances in autism genetics: On the threshold of a new neurobiology. Nat. Rev. Genet. 9: 341-355.
2. Antzelevitch, C., Pollevick, G.D., Cordeiro, J.M., Casis, O., Sanguinetti, M.C., Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., Gelber, P., Bonaros, E.P. Jr, Burashnikov, E., Wu, Y., Sargent, J.D., Schickel, S., Oberheiden, R., Bhatia, A., Hsu, L.F., Haïssaguerre, M., Schimpf, R., Borggrefe, M., and Wolpert, C. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115: 442-449.
3. Arking, D.E., Cutler, D.J., Brune, C.W., Teslovich, T.M., West, K., Ikeda, M., Rea, A., Guy, M., Lin, S., Cook, E.H., and Chakravarti, A. (2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 82: 160-164.
4. Arndt, T.L., Stodgell, C.J., and Rodier P.M. (2005). The teratology of autism. Int. J. Dev. Neurosci. 23: 189-199.
5. Bannwarth, S., Procaccio, V., Rouzier, C., Fragaki, K., Poole, J., Chabrol, B., Desnuelle, C., Pouget, J., Azulay, J.P., Attarian, S., Pellissier, J.F., Gargus, J.J., Abdenur, J.E., Mozaffar, T., Calvas, P., Labauge, P., Pages, M., Wallace, D.C., Lambert, J.C., and Paquis-Flucklinger, V. (2008). Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy. Mitochondrion 8: 136-145.
6. Barrett, C.F., Cao, Y.Q., and Tsien, R.W. (2005). Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J. Biol. Chem. 280: 24064-24071.
7. Barrett, C.F. and Tsien, R.W. (2008). The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl. Acad. Sci. U.S.A. 105: 2157-2162.
8. Bawa, B. and Abbott, L.C. (2008). Analysis of calcium ion homeostasis and mitochondrial function in cerebellar granule cells of adult CaV 2.1 calcium ion channel mutant mice. Neurotox. Res. 13: 1-18.
9. Berridge, M.J., Lipp, P., and Bootman, M.D. (2000). The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1: 11-21.
10. Bezprozvanny, I. and Gargus, J.J. (2008). Calcium signaling disease. J. Gen. Physiol. 132: 1a-32a.
11. 2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca22 channelopathy. Neuron 43: 387-400.
12. 2+ channel activity and inhibitory synaptic transmission. Proc. Natl. Acad. Sci U.S.A. 102: 2590-2595.
13. Chauhan, A. and Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology 13: 171-181.
14. Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.L., Liu, Y., and Zheng, P. (2008). TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205: 2397-2408.
15. 2+ disruption in Alzheimer’s disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58: 871-883.
16. Cook, E.H. Jr, Lindgren, V., Leventhal, B.L., Courchesne, R., Lincoln, A., Shulman, C., Lord, C., and Courchesne, E. (1997). Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60: 928-934.
17. Danial, N.N., Gramm, C.F., Scorrano, L., Zhang, C.Y., Krauss, S., Ranger, A.M., Datta, S.R., Greenberg, M.E., Licklider, L.J., Lowell, B.B., Gygi, S.P., and Korsmeyer, S.J. (2003). BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424: 952-956.
18. DeVivo, D., Bohan, T., Coulter, D., Dreifuss, F., Greenwood, R., Nordli, D. J., Shields, W., Stafstrom, C., and Tein, I. (1998). l-Carnitine supplementation in childhood epilepsy: Current perspectives. Epilepsia 39: 1216-1225.
19. Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., Ferrari, M.D., Herzog, J., van den Maagdenberg, A.M., Pusch, M., and Strom, T.M. (2005). Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366: 371-377.
20. Dodick, D.W. and Gargus, J.J. (2008). Why migraines strike. Sci. Am. 299: 56-63.
21. Du, J., Marchado-Vierira, R., Pivovarova, N.B., Chen, G., Andrews, S.B., and Manji, H.K. (2008). Calcium dysregulation in bipolar disorder: A critical role for Bcl-2 gene polymorphisms in human subjects. J. Gen. Physiol. 132: 32a.
22. Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., and Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39: 25-27.
23. Eeg-Olofsson, O., al-Zuhair, A.G., Teebi, A.S., Daoud, A.S., Zaki, M., Besisso, M.S., and Al-Essa, M.M. (1990). Rett syndrome: A mitochondrial disease? J. Child Neurol. 5: 210-214.
24. Einat, H., Yuan, P., and Manji, H.K. (2005). Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders. Behav. Brain Res. 165: 172-180.
25. Esposito, L.A., Melov, S., Panov, A., Cottrell, B.A., and Wallace, D.C. (1999). Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 96: 4820-4825.
26. Fernandes, H.B., Baimbridge, K.G., Church, J., Hayden, M.R., and Raymond, L.A. (2007). Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington’s disease. J. Neurosci. 27: 13614-13623.
27. Filipek, P.A., Juranek, J., Nguyen, M.T., Cummings, C., and Gargus, J.J. (2004). Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34: 615-623.
28. Filipek, P.A., Juranek, J., Smith, M., Mays, L.Z., Ramos, E.R., Bocian, M., Masser-Frye, D., Laulhere, T.M., Modahl, C., Spence, M.A., and Gargus, J.J. (2003). Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann. Neurol. 53: 801-804.
29. Fillano, J.J., Goldenthal, M.J., Rhodes, C.H., and Marín-García, J. (2002). Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism and developmental delay: HEADD syndrome. J. Child Neurol. 17: 435-439.
30. Finsterer, J. (2006). Central nervous system manifestations of mitochondrial disorders. Acta Neurol. Scand. 114: 217-238.
31. Flavell, S.W. and Greenberg, M.E. (2008). Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31: 563-590.
32. Gargus, J.J. (2003). Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am. J. Hum. Genet. 72: 785-803.
33. Gargus, J.J. (2005). Receptor, transporter and ion channel diseases. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. R.A. Meyers, eds. Wiley-VCH, Weinheim, Vol. 11, pp. 637-711.
34. Gargus, J.J. (2006). Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biol. Psychiatry 60: 177-185.
35. Gargus, J.J. (2008a). Receptor, transporter and ion channel diseases. In: Neurobiology. R.A. Meyers, eds. Wiley-VCH, Weinheim, Vol. 2, pp. 669-742.
36. Gargus, J.J. (2008b). Calcium signaling abnormalities in familial hemiplegic migraine, type 2 (FHM2), a window into autism and polygenic neuropsychiatric channelopathies. J. Gen. Physiol. 132: 19a-20a.
37. Gargus, J.J. (2009). Genetic calcium signaling abnormalities in the CNS: Seizures, migraine and autism. The Year in Human & Medical Genetics 2009. Annals of the New York Academy of Sciences 1151: 133-156.
38. Gargus, J.J. and Imtiaz, F. (2008). Mitochondrial energy-deficient endophenotype in autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4: 198-207.
39. Gargus, J.J. and Shih, C.H. (2007). Monogenic migraine syndromes highlight novel drug targets. Drug Dev. Res. 68: 432-440.
40. Gargus, J.J. and Tournay, A. (2007). Novel mutation confirms seizure locus SCN1A is also FHM3 migraine locus. Ped. Neurol. 37: 407-410.
41. Gladstone, J.P. and Dodick, D.W. (2005). Migraine and cerebral white matter lesions: When to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 11: 19-29.
42. Graf, W.D., Marin-Garcia, J., Gao, H.G., Pizzo, S., Naviaux, R.K., Markusic, D., Barshop, B.A., Courchesne, E., and Haas, R.H. (2000). Autism associated with the mitochondrial DNA G8363A transfer RNALys mutation. J. Child Neurol. 15: 357-361.
43. Hayashi, T. and Su, T.P. (2007). Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca22 signaling and cell survival. Cell 131: 596-610.
44. Hudson, G. and Chinnery, P.F. (2006). Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15: R244-R252.
45. Jacobs, A., Knight, B.P., McDonald, K.T., and Burke, M.C. (2006). Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8). Heart Rhythm 3: 967-970.
46. Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., and Bourgeron, T., and Paris Autism Research International Sibpair Study (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34: 27-29.
47. James, S.J., Melnyk, S., Jernigan, S., Cleves, M.A., Halsted, C.H., Wong, D.H., Cutler, P., Bock, K., Boris, M., Bradstreet, J.J., Baker, S.M., and Gaylor, D.W. (2006). Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B: 947-956.
48. Kaja, S., van de Ven, R.C., Broos, L.A., Veldman, H., van Dijk, J.G., Verschuuren, J.J., Frants, R.R., Ferrari, M.D., van den Maagdenberg, A.M., and Plomp J.J. (2005). Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135: 81-95.
49. Kaplin, A.I., Ferris, C.D., Voglmaier, S.M., and Snyder, S.H. (1994). Purified reconstituted inositol 1,4,5-trisphosphate receptors. Thiol reagents act directly on receptor protein. J. Biol. Chem. 269: 28972-28978.
50. Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., Macleod, N., and Bird, A. (2006). Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol. Cell Biol. 26: 5033-5042.
51. Liu, Z. and Butow, R.A. (2006). Mitochondrial retrograde signaling. Annu. Rev. Genet. 40: 159-185.
52. Ma, S. and Gargus, J.J. (2007). The genetics of neuronal channelopathies. In: Encyclopedia of Life Sciences. Wiley, Chichester.
53. McElroy, S.L. (2004). Diagnosing and treating comorbid (complicated) bipolar disorder. J. Clin. Psychiatry 65: Suppl 15: 35-44.
54. Moretti, P., Bouwknecht, J.A., Teague, R., Paylor, R., and Zoghbi, H.Y. (2005). Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14: 205-220.
55. Morrow, E.M., Yoo, S.Y., Flavell, S.W., Kim, T.K., Lin, Y., Hill, R.S., Mukaddes, N.M., Balkhy, S., Gascon, G., Hashmi, A., Al-Saad, S., Ware, J., Joseph, R.M., Greenblatt, R., Gleason, D., Ertelt, J.A., Apse, K.A., Bodell, A., Partlow, J.N., Barry, B., Yao, H., Markianos, K., Ferland, R.J., Greenberg, M.E., and Walsh, C.A. (2008). Identifying autism loci and genes by tracing recent shared ancestry. Science 321: 218-223.
56. Nelson, E.D., Kavalali, E.T., and Monteggia, L.M. (2006). MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr. Biol. 16: 710-716.
57. Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., and Bezprozvanny, I. (2007). Familial Alzheimer disease-linked mutations specifically disrupt Ca22 leak function of presenilin 1. J. Clin. Invest. 117: 1230-1239.
58. Oliveira, G., Ataíde, A., Marques, C., Miguel, T.S., Coutinho, A.M., Mota-Vieira, L., Gonçalves, E., Lopes, N.M., Rodrigues, V., Carmona da Mota, H., and Vicente, A.M. (2007). Epidemiology of autism spectrum disorder in Portugal: Prevalence, clinical characterization, and medical conditions. Dev. Med. Child Neurol. 49: 726-733.
59. Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., Miguel, T., Borges, L., Vicente, A.M., and Oliveira, C.R. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Dev. Med. Child Neurol. 47: 185-189.
60. Palmieri, L., Papaleo, V., Porcelli, V., Scarcia, P., Gaita, L., Sacco, R., Hager, J., Rousseau, F., Curatolo, P., Manzi, B., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R., Elia, M., Lenti, C., Saccani, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.L., and Persico, A.M. (2008). Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartateaglutamate carrier AGC1. Mol. Psychiatry 2008 Jul 8 [Epub ahead of print].
61. 2+ release via locally derived NADH. Proc. Natl. Acad. Sci. U.S.A. 102: 1357-1359.
62. Pellock, J.M. (2004). Understanding co-morbidities affecting children with epilepsy. Neurology 62 (5 Suppl. 2):S17-S23.
63. Plummer, N.W. and Meisler, M.H. (1999). Evolution and diversity of mammalian sodium channel genes. Genomics 57: 323-331.
64. Pons, R., Andreu, A.L., Checcarelli, N., Vilà, M.R., Engelstad, K., Sue, C.M., Shungu, D., Haggerty, R., de Vivo, D.C., and DiMauro, S. (2004). Mitochondrial DNA abnormalities and autistic spectrum disorders. J. Pediatr. 144: 81-85.
65. Porter, A., Gladstone, J.P., and Dodick, D.W. (2005). Migraine and white matter hyperintensities. Curr. Pain Headache Rep. 9: 289-293.
66. Priori, S.G. and Napolitano, C. (2006). Role of genetic analyses in cardiology. Part I: Mendelian diseases: Cardiac channelopathies. Circulation 113: 1130-1135.
67. Ramoz, N., Reichert, J.G., Smith, C.J., Silverman, J.M., Bespalova, I.N., Davis, K.L., and Buxbaum, J.D. (2004). Linkage and association of the mitochondrial aspartateaglutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry 161: 662-669.
68. Saleh, S., Yeung, S.Y., Prestwich, S., Pucovsky, V., and Greenwood, I. (2005). Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J. Physiol. 568(Pt. 1): 155-169.
69. Schanen, N.C. (2006). Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 15: Spec No 2: R138-R150.
70. Schneider, T. and Przewlocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 30: 80-89.
71. Segall, L., Scanzano, R., Kaunisto, M.A., Wessman, M., Palotie, A. Gargus, J.J., and Blostein, R. (2004). Kinetic alterations due to a missense mutation in the Na, K-ATPase α2 subunit cause familial hemiplegic migraine type 2. J. Biol. Chem. 279: 43692-43696.
72. Segall, L., Mezzetti, A., Scanzano, R., Gargus, J.J., Purisima, E., and Blostein, R. (2005). Alterations in the α2 isoform of the Na, K-ATPase associated with familial hemiplegic migraine type 2. Proc. Nat. Acad. Sci. U.S.A. 102: 11106-11111.
73. Segurado, R., Conroy, J., Meally, E., Fitzgerald, M., Gill, M., and Gallagher, L. (2005). Confirmation of association between autism and the mitochondrial aspartateS glutamate carrier SLC25A12 gene on chromosome 2q31. Am. J. Psychiatry 162: 2182-2184.
74. Sicouri, S., Timothy, K.W., Zygmunt, A.C., Glass, A., Goodrow, R.J., Belardinelli, L., and Antzelevitch, C. (2007). Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart Rhythm 4: 638-647.
75. Sklar, P., Smoller, J.W., Fan, J., Ferreira, M.A., Perlis, R.H., Chambert, K., Nimgaonkar, V.L., McQueen, M.B., Faraone, S.V., Kirby, A., de Bakker, P.I., Ogdie, M.N., Thase, M.E., Sachs, G.S., Todd-Brown, K., Gabriel, S.B., Sougnez, C., Gates, C., Blumenstiel, B., Defelice, M., Ardlie, K.G., Franklin, J., Muir, W.J., McGhee, K.A., MacIntyre, D.J., McLean, A., VanBeck, M., McQuillin, A., Bass, N.J., Robinson, M., Lawrence, J., Anjorin, A., Curtis, D., Scolnick, E.M., Daly, M.J., Blackwood, D.H., Gurling, H.M., and Purcell, S.M. (2008). Whole-genome association study of bipolar disorder. Mol. Psychiatry 13: 558-569.
76. Smith, I.F., Shih, C, Blostein, R, Parker, I., and Gargus, J.J. (2009). Role of NaSK pump in regulation of IP3R calcium channel demonstrated by familial hemiplegic migraine (FHM2) mutations. The Royal Society Meeting on Membrane Transport in Flux: The Ambiguous Interface Between Channels and Pumps. London, May 19, 20, 2008. Phil. Trans. Royal Soc. B. (in press).
77. Spät, A., Szanda, G., Csordás, G., and Hajnóczky, G. (2008). High- and low-calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium 44: 51-63.
78. Splawski, I., Timothy, K.W., Decher, N., Kumar, P., Sachse, F.B., Beggs, A.H., Sanguinetti, M.C., and Keating, M.T. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. U.S.A. 102: 8089-8096.
79. Splawski, I., Timothy, K.W., Sharpe, L.M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P.J., Joseph, R.M., Condouris, K., Tager-Flusberg, H., Priori, S.G., Sanguinetti, M.C., and Keating, M.T. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19-31.
80. Splawski, I., Yoo, D.S., Stotz, S.C., Cherry, A., Clapham, D.E., and Keating, M.T. (2006). CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281: 22085-22091.
81. Stutzmann, G.E., Smith, I., Caccamo, A., Oddo, S., Laferla, F.M., and Parker, I. (2006). Enhanced ryanodine receptor recruitment contributes to Ca22 disruptions in young, adult, and aged Alzheimer’s disease mice. J. Neurosci. 26: 5180-5189.
82. Stutzmann, G.E., Smith, I., Caccamo, A., Oddo, S., Parker, I., and Laferla, F. (2007). Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer’s mouse models. Ann. N.Y. Acad. Sci. 1097: 265-277.
83. Subramaniam, V., Golik, P., Murdock, D.G., Levy, S., Kerstann, K.W., Coskun, P.E., Melkonian, G.A., and Wallace, D.C. (2008). MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: Coordinate regulation of OXPHOS, antioxidant, and apoptotic genes. Biochim. Biophys. Acta 1777: 666-675.
84. Südhof, T.C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903-911.
85. Surmeier, D.J. (2007). Calcium, ageing, and neuronal vulnerability in Parkinson’s disease. Lancet Neurol. 6: 933-938.
86. Szabadkai, G. and Duchen, M.R. (2008). Mitochondria: The hub of cellular Ca22 signaling. Physiology 23: 84-94.
87. Tabuchi, K., Blundell, J., Etherton, M.R., Hammer, R.E., Liu, X., Powell, C.M., and Südhof, T.C. (2007). Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318: 71-76.
88. 2+ channels in trigeminal nociceptive processing. J. Gen. Physiol. 132: 22a.
89. (2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. U.S.A. 99: 13284-13289.
90. 2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell 126: 981-993.
91. Wagner, G.C., Reuhl, K.R., Cheh, M., McRae, P., and Halladay, A.K. (2006). A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate. J. Autism Dev. Disord. 36: 779-793.
92. Weiss, L.A., Escayg, A., Kearney, J.A., Trudeau, M., MacDonald, B.T., Mori, M., Reichert, J., Buxbaum, J.D., and Meisler, M.H. (2003). Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry 8: 186-194.
93. Yan, J., Noltner, K., Feng, J., Li, W., Schroer, R., Skinner, C., Zeng, W., Schwartz, C.E., and Sommer, S.S. (2008). Neurexin 1alpha structural variants associated with autism. Neurosci. Lett. 438: 368-370.
94. Yang, J.L., Weissman, L., Bohr, V.A., and Mattson, M.P. (2008). Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair 7: 1110-1120.
95. Yapici, Z., Dörtcan, N., Baykan, B.B., Okan, F., Dinçer, A., Baykal, C., Eraksoy, M., and Roach, S. (2007). Neurological aspects of tuberous sclerosis in relation to MRIöMR spectroscopy findings in children with epilepsy. Neurol. Res. 29: 449-454.
96. Zhang, H., Li, Q., Graham, R.K., Slow, E., Hayden, M.R., and Bezprozvanny, I. (2008). Full length mutant huntingtin is required for altered Ca22 signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington’s disease. Neurobiol. Dis. 31: 80-88.